Global Sepsis Diagnostic Market Expected to Reach $1.2 Billion by 2030

According to a new report published by Allied Market Research, titled, “Global Sepsis Diagnostic Market," The global sepsis diagnostic market was valued at $569.49 million in 2020, and is estimated to reach $1.2 billion by 2030, growing at a CAGR of 7.8% from 2021 to 2030.

Sepsis is the body’s extreme response to an infection, and is a life-threatening medical emergency. Sepsis occurs when an existing infection sets off a chain reaction throughout the body. It is caused by infections that begin  in the lungs, urinary tract, skin, or gastrointestinal system. High heart rate or low blood pressure, fever, shivering, or feeling very cold, confusion or disorientation, shortness of breath, extreme pain or discomfort, clammy, or sweaty skin are the most commonly witnessed symptoms of sepsis that can quickly progress to tissue damage, organ failure, and death if not treated promptly.

The major driving factors of sepsis diagnostic market size include increase in burden of sepsis and surge in global geriatric population. Furthermore, increase in government funding for sepsis-related research activities and rise in prevalence of infectious diseases are expected to supplement the market growth. However, high costs automated diagnostics devices are expected to impede the market growth. Furthermore, development of rapid diagnosis/point-of-care techniques for early sepsis diagnostics are expected to provide lucrative opportunities to the market players during the forecast period.  On the basis of product type, the sepsis diagnostic market size is categorized into blood culture media, instruments, assay kits & reagents, and software. The blood culture media segment is expected to dominate the market throughout the forecast period, owing to increase in number of sepsis case, surge in geriatric population, high incidence of bloodstream infection, rise in the demand for rapid diagnostic techniques, and high prevalence of infection diseases. However, the instrument segment is expected to register a CAGR of 8.7% during the forecast period, owing to increase in reliance of patients and physicians on  laboratory testing boosts the sepsis diagnostic market growth. 

Depending on technology, the microbiology segment dominated the market in 2020, and is expected to exhibit a prominent growth rate in sepsis diagnostic market analysis, owing to the fact that microbiology allows accurate detection and identification of microorganisms for sepsis diagnosis through the application of culture media tests.

On the basis of method, the conventional diagnostic segment dominated the market in 2020. This segment is expected to exhibit prominent growth rate, owing to cost-effectiveness of conventional diagnostics method as compared to automated diagnostic method.

By usability, the laboratory testing dominated the market in 2020. This segment is expected to exhibit a prominent growth rate, owing to the fact that lab testing has greater accuracy in comparison to POC testing while diagnosing sepsis. On the basis of pathogen, the bacterial sepsis segment accounted for a major share in the global sepsis diagnostics market in 2020. This segment is expected to exhibit a prominent growth rate, due to increase in prevalence of hospital-acquired infections, rise in cases of bacterial sepsis, and increase in number of surgical procedures.

Region wise in sepsis diagnostic industry, North America accounted for more than 8.1% of the sepsis diagnostic market share in 2020, and is expected to remain dominant throughout the sepsis diagnostic market forecast period. This was attributed to the presence of highly develop healthcare system, high adoption of innovative sepsis diagnostics technology, and advancements in the field of sepsis diagnostics. However, Asia-Pacific is projected to register the highest CAGR of 8.9% during the forecast period, owing to surge in demand for sepsis diagnostics solution in countries with high prevalence of infectious diseases, such as China and India.

Key findings of the study

· Depending on product, the blood culture media segment held the largest share in the global market in 2020.

• On the basis of technique, the microbiology garnered the highest share in 2020, and is expected to remain dominant during the forecast period.
• By method, the conventional diagnostic method segment dominated the market 2020, and is  expected to continue this trend during the forecast period.
• As per usability, the laboratory testing segment acquired the largest share in 2020, and is  anticipated to lead in the coming years.
• By pathogen, the bacterial sepsis segment held the largest market share in 2020, and is expected to remain dominant during the forecast period.
• Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 8.9% during the forecast period.